(Q35007983)

5 August 2017

1 reference

title

Introduction. Lipid oxidation products and atherosclerosis (English)

1 reference

5 August 2017

1 reference

Judith Berliner

1

1 reference

5 August 2017

publication date

1 April 2002

1 reference

5 August 2017

published in

Vascular Pharmacology

1 reference

5 August 2017

volume

38

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

187-191

1 reference

Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Evidence for a role of phospholipid oxidation products in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Removal of cholesterol from extrahepatic sources by oxidative mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Oxysterols in cap and core of human advanced atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Novel function of lecithin-cholesterol acyltransferase. Hydrolysis of oxidized polar phospholipids generated during lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Metabolism of oxidized LDL by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Paraoxonase and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Oxidants and antioxidants in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Chemokines and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Quest for fire: seeking the source of pathogenic oxygen radicals in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Identification of biochemical pathways for the metabolism of oxidized low-density lipoprotein derived aldehyde-4-hydroxy trans-2-nonenal in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Platelet-activating factor acetylhydrolases

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population

1 reference

https://api.crossref.org/works/10.1016%2FS1537-1891%2802%2900168-4

7 January 2021

10.1016/S1537-1891(02)00168-4

Identifiers

DOI

1 reference

5 August 2017

1 reference